Related references
Note: Only part of the references are listed.In vivo selection of aac(6')-Ib-cr and mutations in the gyrA gene in a clinical qnrS1-positive Salmonella enterica serovar Typhimurium DT104B strain recovered after fluoroquinolone treatment
Maria de Toro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Impact of Low-Level Resistance to Fluoroquinolones Due to qnrA1 and qnrS1 Genes or a gyrA Mutation on Ciprofloxacin Bactericidal Activity in a Murine Model of Escherichia coli Urinary Tract Infection
Nicolas Allou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
Jacob Strahilevitz et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
Interplay in the Selection of Fluoroquinolone Resistance and Bacterial Fitness
Linda L. Marcusson et al.
PLOS PATHOGENS (2009)
Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1
J. M. Rodriguez-Martinez et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Plasmid-mediated quinolone resistance
Luis Martinez-Martinez et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
A unified anti-mutant dosing strategy
Xilin Zhao et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli
Sonia K. Morgan-Linnell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1
J. M. Rodriguez-Martinez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Mutant selection window hypothesis updated
Karl Drlica et al.
CLINICAL INFECTIOUS DISEASES (2007)
Correlation of quinolone resistance levels and differences in basal and quinolone-induced expression from three qnrA-containing plasmids
JM Rodríguez-Martínez et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum β-lactamase
L Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coli
LL Marcusson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Interaction of plasmid and host quinolone resistance
L Martínez-Martínez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Emerging mechanisms of fluoroquinolone resistance
DC Hooper
EMERGING INFECTIOUS DISEASES (2001)
Share Paper
